Life Sciences and HealthCare

Key Contacts

Our life-sciences group combines seasoned legal professionals and science graduates with in-depth sector understanding, offering comprehensive “one-stop shop” services to domestic and multinational companies throughout all product lifecycle stages.

We assist our clients in navigating their complex business and regulatory obstacles, deals, as well as their IP, product liability, and commercial disputes across a wide range of industry sectors, including pharmaceuticals, biotechnology, medical devices, digital health products, genetic tests, biomedical products, food, vitamins and supplements, healthcare providers, research institutes, and more. Each client benefits from a bespoke approach and tailored strategies aligned with their products and areas of activity. Our team’s background and experience provide us with a unique understanding of the challenges faced by life sciences companies and enable us to advise on all aspects of their activity throughout the entire lifecycle, from early-stage startups to mature enterprises.

Core Capabilities

  • Regulatory Advice and Compliance Programs: Comprehensive counsel on regulatory compliance, navigating investigations and enforcement actions, product registrations, market access and clearances, clinical trials, labeling, promotional activity and advertising requirements, pricing and reimbursement, ensuring adherence to industry and regulatory standards.
    We routinely participate in shaping the industry through legislative processes and the formulation of Ministry of Health procedures and guidelines related to life sciences products.
    Our services also include strategic antitrust and competition law advice related to product registration, collaborations, and market access.
  • Product Liability and Class Actions: Expert handling of product liability claims and defense against individual and class action claims, including complex litigation involving pharmaceutical products, medical devices, and biotechnology innovations.
  • Licensing Agreements: Negotiating and structuring licensing agreements, joint ventures, collaborations, technology commercialization agreements, and other strategic alliances, ensuring robust protection and commercialization of intellectual property assets.
  • Life Science Transactions: Managing corporate transactions including mergers and acquisitions, capital markets transactions, debt financing, private equity investments, venture financing, strategic advisory on public and private offerings, and conducting legal due diligence of life sciences companies.

Our clients include major innovative and generic pharmaceutical companies, medical device companies, biotechnology firms, healthcare startups, academic institutions, healthcare providers, venture capital funds, and private equity funds. We provide tailored guidance on corporate governance, securities compliance, risk management, and other critical operational aspects to help companies navigate complex legal landscapes and achieve their business objectives.

recognition

News & Insights:

Access our legal insights, thought leadership and expert analysis

Updates

Update to Procedure No. 6 of the Ministry of Health – A Breakthrough in Pharmacovigilance Policy?

The Department of Risk Management and Medicinal Information at the Israeli Ministry of Health has published, for the public comments, a draft update to procedure No. 6, titled “Reporting of Adverse Events and New Safety Information”.

Position Application

Subscribe

Get the latest updates straight to your inbox

SHARE

Facebook
LinkedIn
WhatsApp
Email
Print